CoChat

Utilizing the T12 skeletal muscle index on computed tomography images for sarcopenia diagnosis in lung cancer patients

He, Shi, Zhang, Guolong, Huang, Ningbin, Chen, Siting, Ruan, Liang, Liu, Xuanhui, Zeng, Yingchun · 2024 · Asia-Pacific Journal of Oncology Nursing
Cited by 7

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.apjon.2024.100512

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 25

  1. Falcon, 2017, Sarcopenia and the new ICD-10-CM code: screening, staging, and diagnosis considerations, Fed Pract, 34, 24
  2. Petermann-Rocha, 2022, Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis, J Cachexia Sarcopenia Muscle, 13, 86, 10.1002/jcsm.12783 · DOI · Paper page
  3. Bolte, 2022, Association of sarcopenia with survival in advanced NSCLC patients receiving concurrent immunotherapy and chemotherapy, Front Oncol, 12, 10.3389/fonc.2022.986236 · DOI
  4. Yamada, 2023, Clinical utility of psoas muscle volume in assessment of sarcopenia in patients with early-stage non-small cell lung cancer, J Cancer Res Clin Oncol, 149, 3277, 10.1007/s00432-022-04234-4 · DOI
  5. de Jong, 2022, The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients, J Cachexia Sarcopenia Muscle, 13, 1554, 10.1002/jcsm.12967 · DOI
  6. Jang, 2020, Skeletal muscle mass change during chemotherapy: a systematic review and meta-analysis, Anticancer Res, 40, 2409, 10.21873/anticanres.14210 · DOI
  7. Xia, 2020, Sarcopenia and adverse health-related outcomes: an umbrella review of meta-analyses of observational studies, Cancer Med, 9, 7964, 10.1002/cam4.3428 · DOI · Paper page
  8. Nagano, 2019, Rehabilitation nutrition for iatrogenic sarcopenia and sarcopenic dysphagia, J Nutr Health Aging, 23, 256, 10.1007/s12603-018-1150-1 · DOI
  9. Fearon, 2011, Definition and classification of cancer cachexia: an international consensus, Lancet Oncol, 12, 489, 10.1016/S1470-2045(10)70218-7 · DOI · Paper page
  10. Prado, 2008, Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study, Lancet Oncol, 9, 629, 10.1016/S1470-2045(08)70153-0 · DOI · Paper page
  11. Watanabe, 2023, Skeletal muscle area predicts the outcomes of non-small-cell lung cancer after trimodality therapy, Interdiscip Cardiovasc Thorac Surg, 36, 10.1093/icvts/ivad020 · DOI
  12. Wakefield, 2022, The association between thoracic sarcopenia and survival is gender specific in early-stage lung cancer, J Thorac Dis, 14, 4256, 10.21037/jtd-22-273 · DOI · Paper page
  13. Troschel, 2021, Sarcopenia on preoperative chest computed tomography predicts cancer-specific and all-cause mortality following pneumonectomy for lung cancer: a multicenter analysis, Cancer Med, 10, 6677, 10.1002/cam4.4207 · DOI
  14. Sun, 2020, Prognostic significance of low pectoralis muscle mass on preoperative chest computed tomography in localized non-small cell lung cancer after curative-intent surgery, Lung Cancer, 147, 71, 10.1016/j.lungcan.2020.07.008 · DOI
  15. Ishida, 2020, Formula for the cross-sectional area of the muscles of the third lumbar vertebra level from the twelfth thoracic vertebra level slice on computed tomography, Geriatrics (Basel)., 5
  16. Dong, 2020, Identifying sarcopenia in advanced non-small cell lung cancer patients using skeletal muscle CT radiomics and machine learning, Thorac Cancer, 11, 2650, 10.1111/1759-7714.13598 · DOI · Paper page
  17. Tan, 2021, Diagnosing sarcopenia and myosteatosis based on chest computed tomography images in healthy Chinese adults, Insights Imaging, 12, 163, 10.1186/s13244-021-01106-2 · DOI
  18. Li, 2022, Effects of protein supplementation and exercise on delaying sarcopenia in healthy older individuals in Asian and non-Asian countries: a systematic review and meta-analysis, Food Chem X, 13, 10.1016/j.fochx.2022.100210 · DOI
  19. G, 2021, Implications of race and ethnicity in sarcopenia US National Prevalence of Sarcopenia by muscle mass, strength, and function indices, Gerontol Geriatr Res, 4, 126
  20. Brennan-Olsen, 2020, Education, occupation and operational measures of sarcopenia: six years of Australian data, Australas J Ageing, 39, e498, 10.1111/ajag.12816 · DOI
  21. Takamori, 2018, Clinical impact and risk factors for skeletal muscle loss after complete resection of early non-small cell lung cancer, Ann Surg Oncol, 25, 1229, 10.1245/s10434-017-6328-y · DOI · Paper page
  22. Xu, 2023, Diagnosis of sarcopenia using the L3 skeletal muscle index estimated from the L1 skeletal muscle index on MR images in patients with cirrhosis, J Magn Reson Imag, 58, 1569, 10.1002/jmri.28690 · DOI
  23. Yang, 2021, Factors that improve chest computed tomography-defined sarcopenia prognosis in advanced non-small cell lung cancer, Front Oncol, 11
  24. Voulgaridou, 2024, Diagnostic criteria and measurement techniques of sarcopenia: a critical evaluation of the up-to-date evidence, Nutrients, 16, 436, 10.3390/nu16030436 · DOI
  25. Jang, 2020, Skeletal muscle mass loss during cancer treatment: differences by race and cancer site, Oncol Nurs Forum, 47, 557, 10.1188/20.ONF.557-566 · DOI

Cited by

See all 7

Metadata

Authors
He, S., Zhang, G., Huang, N., Chen, S., Ruan, L., Liu, X., & Zeng, Y.
Venue
Asia-Pacific Journal of Oncology Nursing
Publisher
Elsevier BV
Published
2024-06
Volume
11
Issue
6
Pages
100512
ISSN
2347-5625
Cited by
7
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.